VERA THERAPEUTICS INC (VERA) Stock Analyst Earnings Estimates
NASDAQ:VERA - Nasdaq - US92337R1014 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 483.04% | N/A 134.20% | N/A 63.75% | N/A 34.57% | N/A 10.86% | N/A 15.18% | |||||
| EBITDA YoY % growth | -11.08M | -47.81M -331.50% | -34.22M 28.43% | N/A -126.53% | N/A -27.63% | N/A -69.07% | N/A -21.34% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.59M | -48.06M -314.67% | -34.4M 28.42% | -90.9M -164.24% | -102.012M -12.22% | N/A -65.85% | N/A -26.99% | N/A -9.11% | N/A 49.04% | N/A 173.60% | N/A 327.20% | N/A 68.84% | N/A 30.84% | N/A 24.85% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -13.71 | -3.35 75.57% | -2.31 31.04% | N/A -25.52% | N/A -11.26% | N/A 5.03% | N/A 96.67% | N/A 4,330.00% | N/A 73.76% | N/A -3.95% | N/A 40.51% | N/A 16.43% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 -42.29% | -0.86 -54.46% | -0.87 -40.50% | -0.89 -4.40% | -0.97 -13.98% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -46.92M -109.09% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -49.975M -84.90% | -53.438M -71.76% | -55.001M -47.29% | -55.687M -11.82% | -61.059M -22.18% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.85 -88.89% | -0.67 | -0.18 | -26.69% |
| Q2 2024 Q2Q % growth | -0.62 -34.78% | -0.57 | -0.05 | -8.54% |
| Q1 2024 Q2Q % growth | -0.56 30.00% | -0.54 | -0.02 | -3.59% |
| Q4 2023 Q2Q % growth | -0.60 49.15% | -0.52 | -0.08 | -15.84% |
| Q3 2023 Q2Q % growth | -0.45 50.55% | -0.54 | 0.09 | 17.28% |
| Q2 2023 Q2Q % growth | -0.46 16.36% | -0.71 | 0.25 | 34.95% |
| Q1 2023 Q2Q % growth | -0.80 -12.68% | -0.62 | -0.18 | -29.85% |
| Q4 2022 Q2Q % growth | -1.18 -49.37% | -0.92 | -0.26 | -28.07% |
| Q3 2022 Q2Q % growth | -0.91 -152.78% | -0.74 | -0.17 | -23.62% |
| Q2 2022 Q2Q % growth | -0.55 -66.67% | -0.73 | 0.18 | 24.93% |
| Q1 2022 Q2Q % growth | -0.71 94.19% | -0.68 | -0.03 | -3.89% |
| Q4 2021 Q2Q % growth | -0.79 | -0.47 | -0.32 | -66.56% |
| Q3 2021 Q2Q % growth | -0.36 | -0.61 | 0.25 | 40.68% |
| Q2 2021 Q2Q % growth | -0.33 | -0.40 | 0.07 | 17.04% |
| Q1 2021 Q2Q % growth | -12.23 | -1.98 | -10.25 | -516.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.67% | -41.27% | -0.55% | -11.19% |
| Revenue | N/A | N/A | N/A | N/A |